ASLAN Pharmaceuticals Limited, clinical-stage immunology and oncology-focused biopharmaceutical company, on 24th Feb 2020 announced its presentation at the 9^th Annual SVB Leerink Global Healthcare Conference. Dr Carl Firth, Chief Executive Officer, and Stephen Doyle, Chief Business Officer, is scheduled to present an overview of the company on Wednesday, 26 February 2020 at 09:00am EST. The conference will be held on 25-27 February 2020 in New York.